Shattuck Labs, Inc. Common Stock — Grafico, Quotazione e Notizie (NASDAQ:STTK) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 510.25 M
Employee 40
Founded 2016
CEO N/A
Website www.shattucklabs.com
Headquarter Delaware, United States
FIGI BBG00V776CQ7
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

510.25 M Capitalizzazione di mercato

Rapporto prezzo/utili

-5.21

Rapporto prezzo/fatturato

253.99

Notizie

Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK)

TD Cowen conferma rating Buy su Shattuck Labs dopo dati farmaco

Shattuck Labs stock maintained at Buy by TD Cowen on drug data

Piper Sandler avvia copertura su Shattuck Labs con rating Overweight

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

Shattuck Labs: rating del titolo migliorato a Buy da H.C. Wainwright

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

Shattuck Labs al Congresso UEG: Nuove prospettive per il trattamento della IBD